-
Nano-carrier precision delivery to kill melanoma
Time of Update: 2020-12-06
Technology Daily (Reporter Mao Li) Tel Aviv University in Israel recently said that the university's research team designed a nano-carrier drug system for the treatment of skin melanoma.
Because polyglutamate makes up the nanocarbon itself biodegradable, the hybrid drugs it carries will attack cancer cells directly and simultaneously when released.
-
Scientists have shown for the first time that injectable materials are safe and feasible to treat heart disease
Time of Update: 2020-12-04
BEIJING, Sept. 11 (Reporter Sun Self-Law) Reporters from China Institute of Genetics and Developmental Biology ( Institute of Genetic Development) was informed that the Institute Dai Jianwu regenera
-
Buy food online: e-commerce to open enough horsepower to protect the supply
Time of Update: 2020-11-25
" Li Jie said, "because of the new crown pneumonia outbreak, I have rarely gone to the supermarket to purchase, in the fresh e-commerce platform to place an order, the distribution staff can be sent to the community door, safe and convenient." " Spring Festival, under the leadership of her daughter, Li Jie began to buy food from offline to online, and now she has been able to expertly select goods online, payment settlement.
-
3 compound preparations through consistent evaluation from East China Medicine, Fuyuan Medicine
Time of Update: 2020-10-13
On September 16th, the official website of the Drug Administration showed that three compound preparations were evaluated by consistency, namely, the pyridoxine metformin tablets of East China Pharmaceuticals, the potassium amoxicillinclavin tablets of North China Pharmaceuticals and the potassium chloraten hydrochloride tablets of Fuyuan Pharmaceuticals.
-
Xinda Bio and Lilly cooperation in the next city, home-made PD-1 Daboshu will go to North America and Europe
Time of Update: 2020-09-06
in April, the National Drug Administration (NMPA) formally accepted Dabshu's application for a new adaptation for the first-line treatment of non-squamous non-small cell lung cancer and is expected to be approved by the end of this year or early next year.
-
China's first querto-pearl mono-anti-biosymedic drug on the market, Central Europe two-batch layout of the world
Time of Update: 2020-09-02
" this time to obtain the EU GMP certification, Fuhong Hanyu Xuhui base officially became the first GMP factory to obtain the EU GMP certification for the production of independent research and development of antibody biologic drugs, HLX02 also became the first in China to obtain the EU GMP certification of "Chinese nationality" mono-anti-biosimilars, meaning that domestic mono-anti-biopharmaceuticals listed overseas GMP barriers have been broken, China's biopharmaceutical industry to the international significance.
-
Anhui Food and Drug Administration supervises food safety in Huainan
Time of Update: 2020-08-31
December 6, Anhui Province Food Droods Supervision Bureau of Huainan City illegal addition of opium poppy alkali and other non-edible substances special inspection to carry out inspection.
-
A special inspection of medical corruption has come
Time of Update: 2020-08-13
marketing costs remain high, pharmaceutical companies were named recently, a number of listed pharmaceutical companies received the 2019 annual report of the Shenzhen Stock Exchange inquiry letter, asked to explain the proportion of academic promotion fees to sales costs, whether the sales fee rate is at a reasonable level in the industry, and whether there is commercial bribery or commercial bribery to facilitate the situation.
-
Slow-blocking pulmonary triple therapy! AstraZeneca Breztri Aerosphere (Budigeford) has been approved by the U.S. FDA and is listed in China
Time of Update: 2020-07-31
data show that in patients with moderate to severe chronic obstructive pulmonary disease (COPD, COPD, COPD), with 2 duped therapy Bevespi Aerosphere (Grun brommyamin/Fumaawmodoro) and PT009 Breztri Aerosphere statistically significantly reduced the moderate to severe acute exacerbation rates by 24% (p.001) and 13% (p-0.003) (bourdnydd/Fumasinfomotro) respectively.
-
2 billion injections will be the first to be rated! Luoxin PharmaceuticalS antimicrobial application accepted
Time of Update: 2020-07-14
Pharmaceutical Network July 6th, July 3, Luoxin Pharmaceuticals issued a notice that its subsidiary Shandong Luoxin Pharmaceuticals received the State Drug Administration issued the Klinmycin phosph
-
Throw away children's cold medicine
Time of Update: 2020-07-05
children whether cold drugs are safe and effective will be the subject of recent FDA discussion, and several pharmaceutical companies have voluntarily recalled some drugs The flu season is accom
-
U.S. uses embryonic stem cells to grow pancreatic functional cells
Time of Update: 2020-07-04
scientists who have grown human embryonic stem cells into pancreatic functional cells for the first time, a study published online February 20 in Nature Biosciences, marks an important step in the p
-
The drug orientation with the base drug as the core is constantly refining and advancing
Time of Update: 2020-06-26
Again, the "1 plus X" drug use model, which is dominated by essential drugs, opinion paper specifically proposes to optimize the list of antimicrobial supply Medical institutions should optimize the
-
Menarini targets drug tagraxofusp by acquisition of layout CD123
Time of Update: 2020-06-24
Italian drugmaker Menarini Group has announced the acquisition of Stemline Therapeutics for a of up to $677m and acquired the drug Elzonris, which targets CD123 CD123 is expressed in BPDCN and ma
-
Binx Health announces first patients benefit from one-time tests for chlamydia and gonorrhea
Time of Update: 2020-06-17
The binx health io system is a fully automated qualitative test for rapid testing of chlamydia and gonorrhea DNA for female vaginal swabs at medical sites or clinical laboratories These samples are co
